Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | NPY2R | P49146 | 3/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13080641 | 0.88 | HPGD (0.34) | HPGDL3MBTL1KMT2AMAPTALDH1A1 | |
| SCHEMBL13080638 | 0.85 | HPGD (0.38) | HPGDL3MBTL1KMT2AMAPTALDH1A1 | |
| SCHEMBL13080656 | 0.84 | ELANE (0.39) | ELANEL3MBTL1KMT2AMAPTALDH1A1 | |
| SCHEMBL3454435 | 0.84 | ELANE (0.35) | ELANEHPGDL3MBTL1KMT2AMAPT | |
| SCHEMBL13080650 | 0.80 | ELANE (0.38) | ELANEKMT2AMAPTALDH1A1 | |
| SCHEMBL13080646 | 0.80 | ELANE (0.43) | ELANEL3MBTL1KMT2AMAPTNPY2R | |
| SCHEMBL13080652 | 0.80 | ELANE (0.48) | ELANEHPGDL3MBTL1KMT2AMAPT | |
| SCHEMBL3455540 | 0.72 | HPGD (0.33) | HPGDL3MBTL1KMT2AMAPTEPHX2 | |
| SCHEMBL4352150 | 0.72 | HPGD (0.39) | HPGDL3MBTL1KMT2AMAPTALDH1A1 | |
| SCHEMBL11962457 | 0.71 | HPGD (0.31) | HPGDL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8283102-B2 | Photoacid generator, copolymer, chemically amplified resist composition, and method of forming pattern using the chemically amplified resist composition | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2012-10-09 | — | — | US | disclosed |
| US-20100143843-A1 | PHOTOACID GENERATOR, COPOLYMER, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND METHOD OF FORMING PATTERN USING THE CHEMICALLY AMPLIFIED RESIST COMPOSITION | KOREA KUMHO PETROCHEMICAL CO., LTD. | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143843-A1 | PHOTOACID GENERATOR, COPOLYMER, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND METHOD OF FORMING PATTERN USING THE CHEMICALLY AMPLIFIED RESIST COMPOSITION | POLL, PARG, POLH | ELANE 1905/4885HPGD 3773/4885L3MBTL1 4613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.